HHS Secretary Robert F. Kennedy Jr. has stopped federal support for mRNA-based vaccines, including malaria vaccine efforts. Malaria is deadly, causing hundreds of thousands of deaths annually. Research into mRNA malaria vaccines shows promise, with studies suggesting they could significantly… Read More »Malaria mRNA-based vaccines showing promise in preclinical trials
A clinical study revealed a novel approach to deliver a malaria vaccine using mosquitoes as the delivery mechanism. In a small trial, participants showed a strong immune response and high protective efficacy (89%) against malaria. However, challenges remain regarding the… Read More »New malaria vaccine delivered by a mosquito
Although it may seem like all we talk about are the COVID-19 vaccines, there is a new malaria vaccine developed by Oxford University that has shown a strong effectiveness and safety profile in phase 1/2b clinical trials. Control of malaria has been a goal of scientists for a long time, a potential malaria vaccine is something that should be celebrated widely.
If all goes well, the Oxford malaria vaccine could be approved by late 2023, saving children in many parts of the world from this scourge.
A new paper has been published that provides details of the clinical trial, which I will review below.
Read More »New Oxford malaria vaccine shows strong safety and effectiveness